Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients
Nassim Kamar, Florence Abravanel, Olivier Marion, Laure Esposito, Anne Laure Hébral, Chloé Médrano, Joëlle Guitard, Laurence Lavayssière, Olivier Cointault, Marie Bétriace Nogier, Julie Bellière, Stanislas Faguer, Chloé Couat, Arnaud Del Bello, Jacques Izopet
Topics & Concepts
MedicineImmunogenicityAntibodyNeutralizing antibodyTiterVaccinationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)CohortImmunologyVirologyAntibody titerSevere acute respiratory syndromeCoronavirus disease 2019 (COVID-19)Internal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesSARS-CoV-2 detection and testing